Presentation to include 3-year data from all cohorts of the Phase 1 AQUAx Clinical Study - Cohort-level data and individual patient data from bilateral and unilateral cohorts will be presented for ...

As the pharmaceutical industry navigates a series of interconnected industry challenges, the pharma community’s attention turns to Amsterdam. Later this month, major sector players gather for PHARMAP ...

Poster #76954 highlights QTORIN™ rapamycin’s single phase anhydrous gel formulation designed to optimize dermal bioavailability of rapamycin for ...

TNX-4800 is a long-acting anti-Borrelia burgdorferi OspA human monoclonal antibody in development as a single-dose Lyme prophylactic Phase 1 ...

AtomVie Global Radiopharma (AtomVie), a global leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing in GMP manufacturing for clinical and commercial ...

Children in two schools were shown how to pack a wound and stop bleeding as part of police engagement sessions.

PHARMAP 2026 provides the platform for a key industry conversation: how leading pharmaceutical companies are further ...

Cognitive decline, brain fog, and focus loss are no longer slow-burning problems, they’re immediate performance ...

Company expects to initiate a randomized, double-blind, placebo-controlled, adaptive Phase 2 field study in the first half of 2027, pending FDA clearance BERKELEY HEIGHTS, N.J., March 31, 2026 (GLOBE ...

AtomVie Global Radiopharma (AtomVie), a global leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing ...

The Drug, Chemical & Associated Technologies Association (DCAT) held its Member Company Announcement Forum to begin 2026.

Children in two schools were shown how to pack a wound and stop bleeding as part of police engagement sessions.